Table 2.
Late toxicity for localized prostate cancer patients with respect to treatment arm (IG-IMRT vs. RP followed by IMRT)
Toxicity |
Total |
IG-IMRT |
RP + IMRT |
p-value |
---|---|---|---|---|
(n= 96) | (n= 49) | (n= 47) | ||
Genitourinary |
0.145 |
|||
G0 |
30 (31.3%) |
11 (22.5%) |
19 (40.4%) |
|
G1 |
25 (26.0%) |
17 (34.7%) |
8 (17.0%) |
|
G2 |
24 (25.0%) |
12 (24.5%) |
12 (25.5%) |
|
G3 |
17 (17.7%) |
9 (18.4%) |
8 (17.0%) |
|
G4 |
- |
- |
- |
|
Gastrointestinal |
0.095 |
|||
G0 |
85 (88.5%) |
42 (85.7%) |
43 (91.5%) |
|
G1 |
9 (9.4%) |
7 (14.3%) |
2 (4.3%) |
|
G2 |
- |
- |
- |
|
G3 |
2 (2.1%) |
- |
2 (4.3%) |
|
G4 | - | - |